Liver Transplantation and Metastatic Colo-rectal Cancer.
1 other identifier
interventional
25
1 country
1
Brief Summary
Survival of colo-rectal cancer patients after liver transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 colorectal-cancer
Started Feb 2006
Longer than P75 for phase_2 colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 21, 2006
CompletedFirst Posted
Study publicly available on registry
February 22, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedNovember 7, 2023
November 1, 2023
18.1 years
February 21, 2006
November 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
6 years
Secondary Outcomes (1)
Time to progression side-effects
6 years
Study Arms (1)
Liver transplantation
EXPERIMENTALInterventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rikshospitalet-Radiumhospitalet HF
Oslo, 0020, Norway
Related Publications (1)
Foss A, Adam R, Dueland S. Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int. 2010 Jul;23(7):679-85. doi: 10.1111/j.1432-2277.2010.01097.x. Epub 2010 Apr 30.
PMID: 20477993DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Svein Dueland, MD, PhD
Rikshospitalet-Radiumhospitalet RRHF
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, gastrointestinal oncology
Study Record Dates
First Submitted
February 21, 2006
First Posted
February 22, 2006
Study Start
February 1, 2006
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
November 7, 2023
Record last verified: 2023-11